A Helical Structural Nucleus Is the Primary Elongating Unit of Insulin Amyloid Fibrils by Vestergaard, Bente et al.
A Helical Structural Nucleus Is the Primary
Elongating Unit of Insulin Amyloid Fibrils
Bente Vestergaard
1[*, Minna Groenning
2,3[, Manfred Roessle
4, Jette S. Kastrup
1, Marco van de Weert
2,
James M. Flink
3, Sven Frokjaer
2, Michael Gajhede
1, Dmitri I. Svergun
4,5*
1 Department of Medicinal Chemistry, University of Copenhagen, Copenhagen, Denmark, 2 Department of Pharmaceutics and Analytical Chemistry, University of
Copenhagen, Copenhagen, Denmark, 3 Biophysics, Novo Nordisk A/S, Bagsvaerd, Denmark, 4 Hamburg Outstation, European Molecular Biology Laboratory, Hamburg,
Germany, 5 Institute of Crystallography, Russian Academy of Sciences, Moscow, Russia
Although amyloid fibrillation is generally believed to be a nucleation-dependent process, the nuclei are largely
structurally uncharacterized. This is in part due to the inherent experimental challenge associated with structural
descriptions of individual components in a dynamic multi-component equilibrium. There are indications that
oligomeric aggregated precursors of fibrillation, and not mature fibrils, are the main cause of cytotoxicity in amyloid
disease. This further emphasizes the importance of characterizing early fibrillation events. Here we present a kinetic x-
ray solution scattering study of insulin fibrillation, revealing three major components: insulin monomers, mature
fibrils, and an oligomeric species. Low-resolution three-dimensional structures are determined for the fibril repeating
unit and for the oligomer, the latter being a helical unit composed of five to six insulin monomers. This helical oligomer
is likely to be a structural nucleus, which accumulates above the supercritical concentration used in our experiments.
The growth rate of the fibrils is proportional to the amount of the helical oligomer present in solution, suggesting that
these oligomers elongate the fibrils. Hence, the structural nucleus and elongating unit in insulin amyloid fibrillation
may be the same structural component above supercritical concentrations. A novel elongation pathway of insulin
amyloid fibrils is proposed, based on the shape and size of the fibrillation precursor. The distinct helical oligomer
described in this study defines a conceptually new basis of structure-based drug design against amyloid diseases.
Citation: Vestergaard B Groenning M, Roessle M, Kastrup JS, van de Weert M, et al. (2007) A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils.
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Introduction
Amyloid ﬁbrils are associated with critical diseases such as
Alzheimer disease and Type 2 diabetes. In each amyloid
disease, a particular protein or polypeptide aggregates and
forms insoluble ﬁbrils [1]. Moreover, amyloid ﬁbrils play a
critical role in unwanted degradation of a number of protein-
based drugs [2,3]. Insulin ﬁbrillation is a commonly used
example of amyloid ﬁbrillation because amyloid deposits
have been observed in patients after subcutaneous insulin
infusion [4] as well as in vitro, where insulin easily ﬁbrillates,
causing problems during production, storage, and delivery of
insulin-based drugs [2].
The amyloid ﬁbrils share several common structural
properties, in which twisted and unbranched amyloid ﬁbrils
typically have a diameter of about 100 A ˚ and highly variable
lengths up to several microns [5–8]. Furthermore, mature
ﬁbrils are suggested to be composed of intertwined proto-
ﬁbrils built from two to three intertwining protoﬁlaments,
each with a typical diameter of 15–50 A ˚ [6,7,9]. The most
dominant repeating features of presumably all amyloid ﬁbril
structures are suggested cross-b-sheets with the b-strands
running perpendicular to the ﬁbril axis and an inter-strand
spacing of about 4.8 A ˚ [8,10]. Recently, atomic resolution
structures of amyloid-like hexameric peptide segments, which
form such cross-b-sheets, have been determined [11].
Amyloid ﬁbrillation is proposed to be a nucleation-
dependent process [12–16]. For insulin ﬁbrillation, the initial
step has been suggested to proceed through a non-native,
partly unfolded, monomeric intermediate [12], which pro-
ceeds to form an oligomeric nucleus [17,18] prior to
elongation of protoﬁlaments. A more thorough knowledge
of the structure and mechanism behind the formation of
amyloid ﬁbrils in general, and at the early stages of nucleus
formation in particular, is essential for the understanding of
the processes of amyloidosis. It is equally crucial for the
rational design of drugs to inhibit or reverse amyloid
formation, and for the general understanding of the
mechanisms of protein folding and stability, since the ability
to form amyloid ﬁbrils has been proposed to be a generic
feature of all polypeptide sequences [1]. Importantly, it has
been suggested that oligomeric precursors of amyloid ﬁbrils,
and not the mature ﬁbrils themselves, may be cytotoxic
[19,20]. Indeed, there are indications that precursors are the
main cause of toxicity [21]. This further emphasizes the
importance of characterizing such oligomeric precursors, in
the search for therapeutic treatment of amyloid diseases.
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PLoS BIOLOGYA structural characterization of the ﬁbrillation nucleus is
difﬁcult, because at low protein concentrations, this nucleus
is the thermodynamically least-favorable species [22]. How-
ever, a recent mathematical model of the nucleation-depend-
ent ﬁbrillation process suggests that the nucleus becomes
thermodynamically stable and accumulates above the super-
critical concentration [16]. The species is thus, per deﬁnition,
no longer a thermodynamic nucleus, but is deﬁned as a
structural nucleus. The three-dimensional shape of the
structural nucleus is thus identical to the thermodynamic
nucleus present at low concentrations [16]. However, the
structural nucleus is still inherently difﬁcult to isolate and
characterize. Most methods applied for biophysical or
structural characterization of amyloid ﬁbrillation are prob-
lematic because they either disturb the equilibrium of the
ﬁbrillation process (such as in x-ray crystallography or
nuclear magnetic resonance), or the sample suffers from
surface-mediated effects (such as in scanning tunneling
microscopy, atomic force microscopy [AFM], and cryoelec-
tron microscopy [cryo-EM]). In contrast, small-angle x-ray
scattering (SAXS), which yields low-resolution macromolec-
ular structures, allows examination of the ﬁbrillation process
directly in solution, so that the individual components
present during the evolving equilibrium can be studied. We
report a state-of-the-art SAXS analysis of ﬁbrillating insulin
and determine the ab initio low-resolution structure of the
amyloid ﬁbril repeating unit. Moreover, the structure of a
helical oligomer, presumably representing the insulin struc-
tural nucleus, is determined, providing surprising details
regarding its oligomeric composition and organization, with
far-reaching conceptual impact on the current understand-
ing of the early stages of amyloid ﬁbrillation.
Results
Insulin above the Supercritical Concentration
Above a certain supercritical concentration, at which the
rate of the ﬁbril formation reaction becomes almost
independent of the protein concentration, Powers and
Powers demonstrate that the structural nucleus becomes
more stable than the monomer [16]. The concentration
dependency was measured using Thioﬂavin T (ThT) ﬂuo-
rescence. The experimental conditions used in our SAXS
analysis, with insulin concentrations of 5 mg/ml, are above the
supercritical concentration (Figure 1).
X-ray Diffraction Pattern of Insulin Fibrils
A characteristic x-ray ﬁber diffraction pattern was
observed for insulin samples under the experimental con-
ditions employed during the SAXS studies (Figure S3). A
typical meridional signal is seen at 4.8 A ˚ , and an equally
typical equatorial signal is recorded at 10.5 A ˚ . In addition to
the characteristic ThT ﬂuorescence signal, this conﬁrms the
existence of ﬁbrils.
A Distinct Oligomer Elongates the Maturing Fibrils
Time-resolved synchrotron SAXS was applied to study the
insulin ﬁbrillation process in solution, starting from mono-
meric insulin. During the 5-h lag phase, only monomers were
detected (Figure 2 and Table S1), with a small increase in the
average size of the molecules towards the end of the lag phase,
presumably reﬂecting the expected partial unfolding of a
fraction of the monomers. During the 4-h elongation phase, a
signiﬁcant growth of particles is observed leading to drastic
changes in the scattering pattern (Figure 2A). Importantly,
the scattering curves recorded during the elongation phase
could not be described by linear combinations of the
scattering from monomers and mature ﬁbrils. Singular value
decomposition (SVD) analysis further conﬁrmed that three
components contributed signiﬁcantly to the scattering during
the elongation phase (Figure S1). This suggested to us the
presence of monomers, ﬁbrils, and a distinct oligomer,
apparently representing the hitherto largely uncharacterized
structural nucleus. The scattering pattern from the distinct
oligomer (Figure S2A) was evaluated as described in Materials
and Methods. All the individual scattering patterns collected
during ﬁbrillation could be ﬁtted by a linear combination of
the three components yielding their volume fractions (Figure
Figure 1 Estimation of the Supercritical Concentration
The time required for a fibril formation reaction to reach 50% completion
(t50) is plotted against total insulin concentration with both variables at
logarithmic scales. The concentration used for SAXS analysis is 5 mg/ml.
At 5 mg/ml, the rate of fibril formation is independent of the protein
concentrations, hence, above the supercritical concentration.
doi:10.1371/journal.pbio.0050134.g001
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Structure of the Insulin Amyloid Nucleus
Author Summary
Diseases associated with the presence of amyloid structures, such as
Alzheimer and Parkinson disease, are characterized by the presence
of protein aggregates in the form of highly ordered fibrils. This
amyloid fibril formation is also commonly observed for a number of
protein drugs, such as insulin. Detailed information on how and why
these fibrils are formed will be very useful to design compounds and
drugs that may reverse or even prevent fibril formation, but existing
knowledge in this field is still limited. We have studied, in real time,
the fibril formation of insulin using a technique based on scattering
of x-rays (small-angle x-ray scattering [SAXS]). Using SAXS, we
obtained hitherto unprecedented three-dimensional structural
information on these fibrils in solution. Most importantly, we were
able to describe the three-dimensional structure of a crucial
intermediate, which is probably a structural starting point (nucleus)
in the fibril formation process. These results suggest that under our
experimental conditions this crucial intermediate serves both as the
fibrillation nucleus, as well as the elongating species. We propose
that the latter intermediate is an interesting target for small
molecules in order to prevent or reduce amyloid fibril formation.2A and 2B). As expected, the amount of monomeric insulin
decreases gradually. Appearance of large amounts of the
distinct oligomer accompanies the monomer decrease. There
is an additional lag phase of about 1 h between the initial
observation of oligomer formation and the onset of ﬁbril
growth. Most remarkably, the growth rate of the mature
ﬁbrils is proportional to the amount of the oligomer in
solution (Figure 2C), suggesting that the oligomers represent
the building blocks for the growing ﬁbrils. Thus, above the
supercritical concentration, the insulin ﬁbril elongation
likely proceeds primarily by addition of oligomers. Also, the
amount of monomers in solution is close to zero during the
later stages of ﬁbril formation, which further supports the
notion that oligomer addition elongates the protoﬁlaments.
This mechanism is further supported by the shape of these
oligomers, presented below.
The Distinct Oligomer Is a Helical Bead-on-a-String
Assembly
As early as in 1957, Waugh proposed that a nearly
simultaneous interaction of three to four insulin monomers
forms a nucleus [18], and later mass spectroscopy also
revealed a relatively small nucleus [17]. An elongated
association of monomers prior to ﬁbrillation has been
observed by AFM on insulin samples [23]. The existence of
Figure 2 The Insulin Fibrillation Process
(A) SAXS patterns from the insulin solution as a function of time (the successive curves labeled 1 to 15 are displaced one logarithmic unit down for
clarity). Top curve, monomeric insulin, and bottom curve, mature fibril. The time points correspond to the time points visible in (B) and (C). Blue dots
represent experimental data, and red lines show fits from the three-component mixtures (for the bottom curve, fit by the ab initio shape model is
displayed).
(B) Relative volume fractions of the three components present during the insulin fibrillation process. The insulin monomer curve is shown as grey
squares, the helical oligomer curve as blue circles, and the fibril curve as beige triangles.
(C) Comparison of the fraction of oligomer (blue circles and fitted curve) and the rate of fibril formation evaluated by the first derivative of the fibril
fraction curve (beige triangles) as a function of time.
doi:10.1371/journal.pbio.0050134.g002
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Structure of the Insulin Amyloid Nucleussigniﬁcant amounts of an oligomeric species of insulin prior
to the appearance of mature ﬁbrils and throughout the ﬁbril
elongation process was also detected using dynamic light
scattering [24] and time-lapse AFM [25]. In the present study,
we further characterize the low-resolution shape of the
oligomer ab initio that yields a good ﬁt to its scattering
pattern (Figure S2A) and reveals a helical structure with a
length of 200 A ˚ and a twist of 2708, or three quarters of a full
helical turn in the direction of the long axis (Figure 3). The
hydrated volume of the oligomer is 6.4310
4 A ˚ 3, correspond-
ing to an approximate molecular weight of 32 kDa, or 5.6
insulin monomers. Visually, the helical oligomer also appears
as a bead-on-a-string assembly of six units, each with
dimensions comparable to those of insulin monomers (Figure
3). Moreover, using independent rigid-body modeling (Pro-
tocol S1) in terms of the crystallographic model of partially
unfolded insulin at pH 2 [26], the models consisting of ﬁve or
six subunits provide the best ﬁt to the scattering pattern from
the distinct oligomer (Figure S2A). A typical rigid-body model
(Figure S2B) displays six monomers in a helix-like conﬁg-
uration, very similar to that observed in the ab initio model
(Figure 3).
The SAXS Solution Structure of the Repeating Unit of
Insulin Mature Fibrils
The SAXS data collected after 9-h incubation were used to
evaluate the shape and dimensions of the mature ﬁbril. Given
the resolution of the scattering pattern (from about 900 A ˚ to
12 A ˚ ) ,t h eS A X Sd a t ap r o v i d ei n f o r m a t i o na b o u tt h e
organization of the coherently scattering volume inside the
ﬁbril, associated with its repeating unit. Using indirect
Fourier transformation (IFT), the repeating unit has a length
of about 700 A ˚ and a cross-section diameter of about 300 A ˚
(Tables S1 and S2). Ab initio modeling of the ﬁbril was
further performed based on these dimensions, showing an
elliptically shaped repeating unit with overall dimensions of
690 3 390 3 160 A ˚ 3 (for a ﬁt of the ﬁnal model and data, see
the lowest curve in Figure 2A). The length (690 A ˚ ) of this unit
is within the range of helical crossovers of 350 to 940 A ˚
observed with cryo-EM of insulin ﬁbrils [6]. The ﬁbril consists
of three intertwining helical protoﬁbrils (Figures 3 and 4), as
also observed by cryo-EM and AFM [6,7]. Each protoﬁbril has
an average diameter of about 100 A ˚ , a protoﬁbril diameter
that is in accordance with cryo-EM studies [6]. The ﬁbril has a
left-handed helical twist as observed for most amyloid ﬁbrils
[6,27,28]. The hydrated volume of the repeating helical unit of
the ﬁbril (1.44 3 10
7 A ˚ 3), corresponds to an approximate
molecular weight of 7,200 kDa or about 1,240 insulin
monomers.
Given the potential heterogeneity of the mature ﬁbrils and
possible residual contribution of the monomers and
oligomers even at the latest stages of ﬁbrillation, the models
(Figures 3 and 4) represent average shapes of the most
abundant ﬁbrillating units. It should be noted, however, that
the heterogeneity of the ﬁbrils appears to be low, given that
there are only three components in the above model-free
SVD analysis. Note also that the potential heterogeneity of
the mature ﬁbrils does not challenge our results concerning
the presence and volume fractions of the oligomeric species,
since these have been determined independently of the
model of mature ﬁbrils.
A Mechanism for Elongation of Insulin Fibrils
Although one cannot completely exclude the possibility
that ﬁbrils may grow by addition of individual insulin
monomers, the fact that the growth rate is proportional to
Figure 3 The Three Components Present during the Insulin Fibril Elongation Phase at Relative Scale
The insulin monomer is shown in grey in the lower left corner, the ab initio structure of the helical oligomer in blue, and the ab initio structure of the
repeating helical unit of the fibril in beige (in front and side view). The inset shows the oligomer in a zoom box. Three intertwining protofibrils appear
from the ab initio model of the repeating unit of the fibril. Overall dimensions are marked on the figure. Individual spheres in the oligomer and the
repeating helical unit represent the smallest units during ab initio modeling.
doi:10.1371/journal.pbio.0050134.g003
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Structure of the Insulin Amyloid Nucleusthe amount of oligomers strongly suggests that incorporation
of the latter is the predominant mechanism of elongation.
Moreover, the helical shape of the oligomer (Figure 3) is
ideally suited for entering a protoﬁlament. We have
generated a tentative model of the arrangement of intertwin-
ing helical oligomers into dense protoﬁlaments, assuming
that elongation of protoﬁlaments is directed by oligomer
association. Figure 4 displays such a model with a central
cavity in which the cross-section contains eight helical
oligomers (see Video S1 for the stepwise construction of the
protoﬁlament by the addition of helical oligomers). Fourteen
repeats of the length of these eight helical oligomers would
form a full turn of one protoﬁlament across three ﬁbril
repeating units. Two protoﬁlaments presumably intertwine
to form the protoﬁbrils, yielding an average protoﬁbril
diameter of about 100 A ˚ . Finally, three protoﬁbrils intertwine
to form the mature ﬁbril (see Video S2 for a movie on the
stepwise construction of the mature ﬁbril from protoﬁla-
ments). Hence, a total of 224 oligomers would build up one
full turn of the protoﬁbril. When following one single
protoﬁbril across three repeating ﬁbril units, the protoﬁbril
will have traversed all three positions of the three strands that
are visible within one ﬁbril repeat. Thus, the volume and
estimated molecular weight of the coherently scattering unit
must correspond to the calculated number of 224 helical
oligomers that deﬁne our structural model, which indeed is
the case, and the suggested packing is in agreement with the
molecular weights of 32 and 7,200 kDa of the oligomer and
the helical repeat of the mature ﬁbril, respectively. In the
suggested packing of the protoﬁlament, the helical oligomer
is preshaped for interactions with other oligomers, and all
subsequent oligomer additions elongate the protoﬁlament.
Moreover, oligomer additions are possible in both directions.
Thus, our model suggests that above the supercritical
concentration, the helical oligomer is both the structural
nucleus and the elongating building block of insulin amyloid
ﬁbrils.
Figure 4 Model for Assembly of the Distinct Insulin Oligomers into Protofilaments, Protofibrils, and Fibrils
(A) Eight helical oligomers (shown in a color scale from purple through red to light yellow) intertwine by simultaneous rotation and translation to form
the protofilament. Eight additional precursors in grey nuances form the open ends of the model. Side and top views are shown.
(B) Two protofilaments presumably intertwine to form the protofibrils, with an average diameter of 100 A ˚ (top view, intertwining not depicted). An
orange ellipse marks the outer boundaries of one protofibril.
(C) Three protofibrils (shown in orange, yellow, and red) intertwine to form the mature insulin amyloid fibril. Shown are side and front views. Four
repeats of the ab initio SAXS structure of the coherently scattering unit of the fibril (Figure 3) are shown in beige semi-transparent dots superimposed
on the front view as well as separately in solid spheres. The latter is rotated 258 around the elongating axis compared to the front view. An oligomer
(blue) is superimposed onto the fibril model. See Videos S1 and S2 for two movies visualizing the model of protofilament and fibril assembly. The
figures were generated using PyMol (DeLano Scientific).
doi:10.1371/journal.pbio.0050134.g004
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Structure of the Insulin Amyloid NucleusDiscussion
The existence of oligomeric species during the amyloid
ﬁbrillation process is not unique for insulin ﬁbrillation and
has previously been reported, e.g., for b-amyloid peptide [29],
b-2-microglobulin [30], phosphoglycerate kinase [31,32], a
fragment of Syrian hamster prion protein [32,33], and
myoglobin with polyglutamine insertions [34]. The overall
sizes of some of these aggregates are compatible with the
insulin oligomer described in this study. An insulin ﬁbrilla-
tion study using dynamic light scattering also reports
signiﬁcant amounts of oligomers of similar size [24].
Interestingly, the b-amyloid peptide oligomers revealed by
scanning tunneling microscopy appeared as a bead-on-a-
string–like assembly of individual monomers [29], strikingly
similar to the present model of insulin oligomers. Thus, the
new structural ﬁndings presented here may reveal generic
features of amyloid ﬁbrillation.
The importance of monomeric insulin for ﬁbrillation has
been reported in many studies [12,13] and explained by the
need for a partial unfolding of the monomer prior to
association into amyloid ﬁbrils. This is corroborated by
Fourier transform infrared spectroscopy and circular dichro-
ism studies, showing that a signiﬁcant conversion of a-helical
to b-sheet structure accompanies formation of insulin
amyloid ﬁbrils [2,12]. The presence of repeating cross-b-
sheets perpendicular to the ﬁbril axis with an inter-strand
spacing of about 4.8 A ˚ in the present insulin ﬁbrils was
conﬁrmed by x-ray diffraction (Figure S3). In the case of the
oligomers of b-amyloid peptide [29], which have a similar
appearance to the insulin structural nucleus, b-strands are
directly observed [29], and a structural conversion accom-
panying oligomer formation is also observed for insulin [24].
However, it remains to be shown whether the structural
conversion of insulin to a b-structure occurs prior to or
during structural nucleus formation, because insulin mono-
mers substantially refolded into b-structure have never been
isolated. Under amyloidogenic conditions, a partly modiﬁed
structure has been described, although a central natively
folded core remains [35].
Assuming that a b-sheet with strands separated by 4.8 A ˚
runs parallel to the long axis of the distinct helical oligomer
with a length of 200 A ˚ , this corresponds to approximately 40
b-strands with a relative twist of each b-strand in the b-sheet
of about 78. Based on this rationale, each monomer of the
oligomer should accommodate six to seven b-strands. Small
peptide segments of only three or four residues and several
hexa-peptides from insulin have been shown to form amyloid
ﬁbrils [36] and crystals with amyloid features [37], respec-
tively. This suggests that insulin is, at least in theory, able to
adopt such a structure, as it has 51 amino acids. It is known
that the two interchain and one intrachain disulﬁde bonds in
insulin are accommodated in ﬁbrils [6], and it remains to be
shown how insulin is able to accommodate this in such a b-
sheet–rich structure. Another issue to consider is the recent
theoretically based suggestion that a-sheets, and not b-sheets,
may form the repeating backbone in the oligomer [38,39].
These conformations cannot be distinguished within the
helical insulin oligomer due to the limited resolution of the
SAXS data.
The nucleation polymerization model suggests that parti-
ally unfolded monomers form an oligomeric nucleus,
followed by the elongation process proceeding via direct
addition of structurally non-native monomers [12,40]. How-
ever, in our studies, performed above the supercritical
concentration, the oligomeric species is present in high
amounts during ﬁbrillation, and the amount is proportional
to the rate of ﬁbril elongation. Although Powers and Powers
[16] consider elongation only via monomer addition, they
also note that it seems physically realistic that the oligomers
would associate. This is further supported by the observation
of b-sheets in ﬁbrillar oligomers [29]. Although elongation of
protoﬁlaments by helical oligomer association appears
structurally feasible, we cannot strictly rule out that elonga-
tion occurs at least in part through monomer addition. This
would, however, imply that the oligomer dissociates into
monomers at rates comparable to the elongation rate of the
growing ﬁbrils. Thus, the amount of oligomers would
decrease prior to or simultaneous with the appearance of
ﬁbrils [16]. In contrast, we observe the highest amount of
oligomers not at the start of the ﬁbril growth, but rather
when the rate of elongation is maximal. The elongation of
ﬁbrils also continues after the monomer concentration is no
longer detectable, serving as further argument in favor of the
‘‘elongation via the structural nucleus’’ mechanism.
An elongation through oligomer assembly was proposed
for a peptide derived from the prion protein Sup35 [41].
Fluid oligomeric species was observed and hypothesized to be
structurally distinct from the nucleus. The oligomeric species
was suggested to change conformation upon interaction with
the nucleus, thus speeding up the assembly process. It is
unclear whether the experiments by Serio et al. [41] were
performed below supercritical concentration or, like ours,
above the supercritical concentration, because the super-
critical concentration, to our knowledge, has not yet been
established for Sup35. The oligomeric species we observe
does accumulate above the supercritical concentration (and
thus according to Powers and Powers [16] should correspond
to the structural nucleus), and it reveals a distinct helical
shape strikingly suitable to associate with other helical
oligomers (see Video S1). Of course a conformational change
may happen during the association of the structural nuclei in
the elongating protoﬁlaments, but our modeling shows that
such a conversion is not required for the elongation of
protoﬁlaments via the assembly of structural nuclei.
In summary, we present experimental evidence for the
accumulation of a helical oligomeric species, which has
previously been suggested to be the structural nucleus. In
contrast to the numerical simulation of elongation via
monomer addition proposed by Powers and Powers, our
experimental results demonstrate that the amount of the
structural nucleus in solution determines the rate of
elongation. The shape of the structural nucleus is uniquely
well suited for forming the protoﬁlaments, obviating the need
for conformational changes in the nucleus before associating
into the growing protoﬁlaments.
A secondary nucleation mechanism after the primary
nucleus formation has been proposed for insulin ﬁbrillation
[23,42,43]. Such mechanisms may be branching, fragmenta-
tion, and nucleation on the ﬁbril surface. These features
would not be distinguishable in the current study, since the
scattering units present in solution at all times would still be
oligomers and mature ﬁbril repeating units, irrespective of
the site of secondary nucleation.
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Structure of the Insulin Amyloid NucleusOur model of a dense protoﬁlament structure has a central
cavity (Figure 4A and 4B). Such a cavity has been proposed in
some, but not all, models of amyloid protoﬁlaments [44–46],
e.g., in a b-helical model for poly-glutamine [47] and in hollow
nanotube structures observed for amyloid ﬁbrils, e.g., Ab(1–
40) [48] and Ab(1–25) [49]. Although no high-resolution
structure of a mature amyloid ﬁbril is currently available, it
appears that amyloid ﬁbrils possess common structural
features, the most dominant being the high content of b-
sheets with b-strands perpendicular to the longest and
elongating axis of the ﬁbril [8]. This might suggest a common
structural principle for the mechanism of ﬁbril formation for
several amyloid proteins. The helical oligomer preshaped for
ﬁbril formation could represent a generic principle for the
building blocks in amyloid ﬁbril formation, which also may
represent the structural scaffold followed during monomer
addition at subcritical concentrations.
This study demonstrates the power of SAXS analysis on
data from amyloid systems, since it is possible to separate
scattering contributions from different species present
during ﬁbrillation. The method allows determination of
both the amount and the low-resolution structure of the
species in solution. For amyloid systems characterized by
nucleated polymerization, the thermodynamically unfavor-
able nucleus becomes stable above supercritical concentra-
tions, and is deﬁned as a structural nucleus [16]. Here, we
report experimental evidence for the accumulation of the
structural nucleus in insulin ﬁbrillation and characterize its
structure. This oligomer has a distinct helical structure in
solution, and the correlation between the amount of helical
oligomer present in solution and the growth rate of the
mature ﬁbrils suggests that it is the oligomer that primarily
elongates the growing protoﬁlaments. Using supercritical
concentrations, the potential toxicity of accumulating
oligomers of various amyloid proteins could be investigated.
The oligomer is conceptually central for the understanding
of the early stages of amyloid ﬁbrillation. The low-resolution
model and documented presence of large amounts of
oligomers can facilitate the search of new strategies for
preventing or reversing insulin ﬁbrillation or amyloid
ﬁbrillation in general, e.g., by hindrance of structural nucleus
formation and/or packing of the helical oligomer into
protoﬁlaments.
Materials and Methods
Materials. Human zinc insulin was obtained from Novo Nordisk,
http://www.novonordisk.com. All other chemicals were of analytical
grade.
Determination of supercritical concentration. A total of 0.06–12-
mg/ml insulin in 20% acetic acid (pH 2.0), with 0.5 M sodium chloride
was ﬁbrillated at 45 8C on a Fluostar Optima plate reader from BMG
Labtechnologies (http://www.bmg-labtechnologies.com).
X-ray diffraction. Insulin (5 mg/ml) in 20% acetic acid (pH 2.0),
with 0.5 M sodium chloride was ﬁbrillated at 45 8C on a Fluostar
Optima plate reader from BMG Labtechnologies. Fibrils were
centrifuged at 18,000 g on a Hettich centrifuge and dried in a
desiccator. X-ray synchrotron data were collected at MAXLAB
beamline 911–3, Lund, Sweden, using a MarMosaic 225 detector at
20 8C; k¼1.3 A ˚ , and a 350-mm specimen:detector distance during 30-
s exposure time.
SAXS data collection and reduction. A pellet of human insulin was
dissolved at 5 mg/ml in 20% acetic acid with 0.5 M sodium chloride, at
t ¼ 0 (Table S1). The sample was kept and measured at 45 8C
approximately every 15 min. Zinc acetate was added to the
background buffers corresponding to two Zn
2þ ions per insulin
hexamer in the protein samples. Synchrotron scattering data were
collected on the X33 camera of the European Molecular Biology
Laboratory on DORIS III (Deutsches Electronen Synchrotron [DESY],
Hamburg, Germany) at a wavelength of 1.5 A ˚ , using a MAR345 Image
Plate detector, in the momentum transfer range 0.01 , s , 0.50 A ˚  1 (s
¼ 4p sinh/k, where h is half the scattering angle) with 3-min exposure
times. Selected insulin samples exposed repetitively did not result in
detectable radiation damage. Data analysis was performed using the
software suite ATSAS 2.1 [50]. The data reduction was done using the
program PRIMUS [51], and the molecular masses of the solutes were
estimated by comparing the extrapolated forward scattering I(0) with
that of a reference solution of bovine serum albumin (Table S1). IFT
were evaluated by the program GNOM [52], providing estimates of
distance distribution functions, including the radii of gyration Rg and
maximal distances (Dmax) within the particles.
SVD analysis and decomposition of data curves into monomers,
oligomers, and ﬁbrils. SVD analysis was performed by the program
SVDPLOT [51] using all the measured datasets to detect the number
of independent components (Figure S1). The program OLIGOMER
[51] was employed to represent the experimental data by linear
combinations of the scattering from individual components (mono-
mers, oligomers, and ﬁbrils) and to compute their volume fractions
(Figure 2B). The calculated scattering from a monomer of insulin
(partially unfolded monomers at acidic pH, pdb-ﬁle 1GUJ) and the
low-pass–ﬁltered experimental scattering from the coherent unit of
the ﬁbril after 9-h incubation were employed. To ﬁnd the ﬁrst
representation of the scattering pattern from the oligomer, several
tentative models were built assuming the oligomer to be from dimers
to hexadecamers constructed in long, ﬂat, zigzag, or compact
compositions. The representation was selected for which
OLIGOMER yielded overall best agreement between the experimen-
tal data measured during the elongation phase and the linear
combinations of the three components. Then the volume fraction of
the oligomer was set to zero, and those of the monomers and ﬁbrils
were kept at the values for the three-component ﬁt. The scattering
from the oligomer was computed as the average of all the residuals
between the experimental data and two-component ﬁts. This
decomposition ensures that the scattering curve representing the
oligomer is independent of potential heterogeneity of the mature
ﬁbrils, because the contribution of the latter is removed. Thus, the
determination of the volume fractions during ﬁbrillation and the
modeling of the structural nucleus are independent both of the
heterogeneity of the mature ﬁbrils and of the modeling of the helical
ﬁbril repeat.
Modeling of insulin ﬁbril and oligomer. Ab initio shapes of the
insulin ﬁbril repeat and the distinct oligomer were obtained using the
program DAMMIN [53]. The program employs a simulated annealing
protocol to search for a compact bead model minimizing the
discrepancy between the experimental and calculated curves at low
resolution (up to s about 0.1–0.2 A ˚  1). Based on the best approximat-
ing three-parameter body as computed by the program BODIES [51],
the search volume for the ﬁbril repeat was an ellipsoid with half-axes
of 350, 250, and 150 A ˚ using 35,000 spheres. Individual jobs were
loaded into a Linux cluster, and 20 independent models were
averaged using the program DAMAVER [54]. The resulting model was
used as input for subsequent runs of 20 individual models, for a total
of ﬁve reﬁnements. Likewise, the oligomer shape was calculated
inside a sphere with a diameter of 200 A ˚ , and gradually reﬁned over
three runs using an average of 20 individual models as input. The
ﬁnal averaged and ﬁltered models also yielded the excluded volume
of the hydrated particle.
Supporting Information
Figure S1. Singular Value Decomposition
(A) A plot of eigenvalues as a function of the ordinal number of the
component; the number of signiﬁcant eigenvalues corresponds to the
number of species signiﬁcantly contributing to the scattering data.
(B) A plot of the ﬁrst six eigenvectors normalized by the appropriate
eigenvalue. Successive eigenvectors are displaced by unity along the
vertical axis for clarity, with the ﬁrst eigenvector displayed at the top
and the last at the bottom.
It is seen in (A) that the ﬁrst three eigenvalues signiﬁcantly exceed the
rest, and in (B), that the eigenvectors starting from the fourth from
the top contain essentially noise components. Both plots thus show
that three scattering species are present in the solutions.
Found at doi:10.1371/journal.pbio.0050134.sg001 (29 KB PDF).
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Structure of the Insulin Amyloid NucleusFigure S2. Fit of the Models of the Insulin Oligomer to the Scattering
Data
(A) Scattering from the oligomer (blue) and the computed curves
from its ab initio model (red curve; model shown in Figure 3) and
from the typical rigid-body model containing six insulins (green
curve; model shown in surface representation in [B]). Partial overlap
between monomers 5 and 6 may be caused by the use of only partly
unfolded monomers, which are still mainly a-helical. Individual
monomers in the oligomer are expected to consist of mainly b-
structure and thus be signiﬁcantly different than the native-like
monomers used in this analysis. However, no radically unfolded
monomer structures have been described, for which reason, native-
like monomers are used. The resulting composition still has a striking
resemblance to the ab initio low-resolution model, thus conﬁrming
the validity of the ab initio model.
Found at doi:10.1371/journal.pbio.0050134.sg002 (54 KB PDF).
Figure S3. X-ray Diffraction of Insulin Amyloid Fibrils
X-ray diffraction pattern of dry insulin amyloid ﬁbrils prepared in
20% acetic acid (pH 2.0) and 0.5 M NaCl. The diffraction pattern
shows a dominant reﬂection at 4.8 A ˚ on the meridian (M) and
reﬂections at 10.5, 14.5, and 30 A ˚ on the equator (E).
Found at doi:10.1371/journal.pbio.0050134.sg003 (218 KB TIF).
Protocol S1. SASREF
Rigid-body modeling was used as a complementary approach to
oligomer ab initio modeling, and the program SASREF was
employed. SASREF [55] uses simulated annealing to optimize the
conﬁguration of subunits while ﬁtting to the SAXS data. Four to
seven insulin monomers were tested, even though native monomers
are not expected to form the oligomer, and ﬁve or six monomers
gave the best ﬁt. Most importantly, the helical organization of
subunits was recurring, thus conﬁrming the ab initio DAMMIN
shape.
Found at doi:10.1371/journal.pbio.0050134.sd001 (21 KB DOC).
Table S1. Overall Physical Parameters from Individual SAXS Data
Files
Rg and I(0) have been calculated using GNOM also providing
estimates of maximal distances (Dmax) within the scattering particles.
Molecular masses are estimated by comparing extrapolated forward
scattering I(0) with that of a reference solution of bovine serum
albumin. Rg was also calculated from Guinier approximation. The
data from 308 min and on do not have the correct Guinier range, i.e.,
estimates are approximate.
Found at doi:10.1371/journal.pbio.0050134.st001 (45 KB DOC).
Table S2. Optimizing the IFT
For an optimal IFT, a systematic variation of Dmax was made. The
table shows the overall estimate of the distance distribution
functions, as calculated in GNOM. A Dmax of 70 nm was chosen and
used for the ab initio modeling in accordance with the approxima-
tion from BODIES. However, for completeness, in the subsequent
modeling, the elliptical initial search volume in DAMMIN was varied
between 35–45 nm, 20–30 nm, and 15–25 nm for the half-axes a, b,
and c, respectively, yielding best ﬁts using half-axes of 350, 250, and
150 A ˚ .
Found at doi:10.1371/journal.pbio.0050134.st002 (36 KB DOC).
Video S1. Build-Up of Protoﬁlament from the Helical Oligomer
The assembly of the helical insulin oligomer (structural nucleus) into
a protoﬁlament is shown. Sixteen helical oligomers enter the growing
protoﬁlament one by one, and thereby elongate the growing
protoﬁlament. It is evident that the oligomer is preshaped for
protoﬁlament formation. Individual oligomers are colored on a color
scale from dark violet through red, orange, and yellow to white. The
eight central oligomers are fully packed against other oligomers,
whereas each end of the protoﬁlament has four oligomers that are
open to form contacts with further elongating oligomers. For
simplicity, only single oligomers are shown entering the protoﬁla-
ment ends. Note that the colloidal coagulation theory, as described by
Smoluchowski [56], is compatible with the model. The shape of the
oligomer makes it possible that each individual oligomer can
associate with either single oligomers or multimers of oligomers, just
as multimers of oligomers can associate end to end.
Found at doi:10.1371/journal.pbio.0050134.sv001 (3.2 MB MPG).
Video S2. Formation of Fibrils from Protoﬁlaments
The protoﬁlament is rotated 3608 and, subsequently, 908 to show the
top view. A second protoﬁlament is shown in the same view. The two
protoﬁlaments presumably intertwine to form the protoﬁbril. The
view changes after zooming in to show the protoﬁbril surface in
orange. The view rotates back 908 and then zooms out. Then the three
intertwining protoﬁbrils are shown in orange, red, and yellow,
respectively, during two 3608 rotations. Following that, four ab initio
models of the ﬁbril helical repeat (the coherently scattering unit) are
superimposed in grey during four full rotations, changing the view to
include or exclude the model of the three intertwining protoﬁbrils.
The movie was generated using PyMol (DeLano Scientiﬁc, http://www.
pymol.org).
Found at doi:10.1371/journal.pbio.0050134.sv002 (2.0 MB MPG).
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